Establishment and outcomes of a model primary care pharmacy service system

American Journal of Health-System Pharmacy

Volumn 61, Issue 5, 2004, Pages 472-482

  Carmichael, Jannet M ^a,b,e   Alvarez, Autumn ^c   Chaput, Ryan ^c   Dimaggio, Jennifer ^d   Magallon, Heather ^c   Mambourg, Scott ^c  

^a and Clinical Center (MIRECC)   (United States)

^b UNIVERSITY OF NEVADA   (United States)

^c VA Sierra NV Hlth Care S (VASNHCS)   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e NONE   (United States)

Author keywords

Economics; Outcomes; Patient care; Pharmaceutical services; Pharmacists; Primary care; Quality assurance

Indexed keywords

ARTICLE; AUTOMATION; COMPUTER SYSTEM; COST EFFECTIVENESS ANALYSIS; DRUG MONITORING; GOVERNMENT; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE FACILITY; HEALTH CARE QUALITY; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; LEADERSHIP; OUTCOMES RESEARCH; PATIENT CARE; PHARMACIST; PHARMACY; PHYSICIAN; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; WORKLOAD;

EID: 1542287612     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/61.5.472     Document Type: Article

References (35)

1. Farrar JT. Guidance for the implementation of primary care in Veteran Health Administration (VHA). VHA Directive. 1994; Oct 6.
2. Carmichael JM, O'Connell MB, Devine B et al. Collaborative drug therapy management by pharmacists: a white paper from the American College of Clinical Pharmacy. Pharmacotherapy. 1997; 17:1050-61.
3. Hirsh J, Dalen JE, Anderson DR et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest. 2001; 119:8S-21S.
4. Ansell J, Hirsh J, Dalen J et al. Managing oral anticoagulant therapy. Chest. 2001; 119:22S-38S.
5. Levine MN, Raskob G, Landefeld S et al. Hemorrhagic complications of anticoagulant treatment. Chest. 2001; 119:108S-21S.
6. DiMaggio J, Mambourg S. Improving quality of care and efficiency of our anticoagulation clinic through implementation of a software service. Paper presented at Western States Residency Conference. Pacific Grove, CA; 2003 May.
7. General guideline for establishing medication prescribing authority for clinical nurse specialists, clinical pharmacy specialists and physician assistants. VHA Directive. 1995; Mar 3.
8. Scope of practice for clinical pharmacy specialists. VHA Directive. 1996; May 7.
9. Establishing medication prescribing authority for clinical nurse specialists, nurse practitioners, clinical pharmacy specialists and physician assistants. VHA Directive. 2003; Jan 28.
10. Carmichael JM. Do pharmacists need prescribing privileges to implement pharmaceutical care? Am J Health-Syst Pharm. 1995; 52:1699-701.
11. Patchin G, Carmichael JM. Drug compliance analysis using predefined drug use criteria. Pharm Ther. 1994; 19:225-34.
12. Isetts BJ, Sorensen TD. Use of a student-driven, university-based pharmaceutical care clinic to define the highest standards of patient care. Am J Pharm Educ. 1999; 63:443-9.
13. Gouveia WA, Carmichael JM. Applying patient outcomes and pharmacoeconomics in patient care. Am J Health-Syst Pharm. 1995; 52(suppl 3):S3-5.
14. Mountan M, Patchin G, Carmichael JM. Primary prevention lipid clinic to reduce 10-year risk of CHD. Paper presented at Western States Residency Conference. Pacific Grove, CA; 2002 May.
15. National Heart, Lung, and Blood Institute. National Cholesterol Education Program clinical practice guidelines for cholesterol management in adults (ATP III). www.nhlbi.nih.gov/guidelines/cholesterol/atp3full.pdf (accessed 2001 Oct 1).
16. Management of dyslipidemia in primary care. Clinical practice guideline. www. oqp.med.va.gov/cpg/DL/DL_base.htm (accessed 2003 Sep 1).
17. Shepherd J, Cobbe SM, Ford I et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995; 333:1301-7.
18. Downs JR, Clearfield M, Weis S et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. JAMA. 1998; 279:1615-22.
19. Baca ML, Lardinois CK, Foster BA et al. Pharmacy-based management of cardiovascular risk factors in patients with diabetes. Paper presented at National VA Diabetes Symposium. Alexandria, VA; 2002 Mar.
20. Cordi SL, Lardinois CK, Foster BA et al. Management of hypertension in patients with diabetes mellitus: a pharmacy based clinic. Paper presented at ASHP Midyear Clinical Meeting. Las Vegas, NV; 2000 Dec.
21. Sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI). Arch Intern Med. 1997; 157:2413-46.
22. Management of diabetes mellitus. Washington, DC: Veterans Health Administration, Office of Quality and Performance, 1999 Dec; publication no. 10Q-CPG/DM-01.
23. Carmichael JM, Patchin G, Savage L. Database analysis used to identify the inappropriate prescribing of PPIs. Paper presented at Western States Residency Conference. Pacific Grove, CA; 2000 May.
24. Meyer KL, Carmichael JM. Review of gastroesophageal reflux disease (GERD) and a step-down program for patients on long term proton pump inhibitors. Drug Topics. 2001; Nov 19:41-50.
25. Consensus Statement: Helicobacter pylori in peptic ulcer disease. Bethesda, MD: National Institute of Health, 1994.
26. Patchin G, Wieland KA, Carmichael JM. Six months' experience with a pharmacist-run Helicobacter pylori treatment clinic. Am J Health-Syst Pharm. 1996; 53:2081-2.
27. Nguyen BA, Mambourg SE. Therapeutic switch of atorvastatin to simvastatin. Paper presented at Western States Residency Conference. Pacific Grove, CA; 1999 May.
28. Dart A, Jenums G, Nicholson G et al. A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients with hypercholesterolemia. Am J Cardiol. 1997; 80:39-44.
29. Malone DC, Carter BL, Billups SJ et al. An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans: the IMPROVE study. Pharmacotherapy. 2000; 20:1149-58.
30. Ellis SL, Billups SJ, Malone DC et al. Types of interventions made by clinical pharmacists in the IMPROVE study. Pharmacotherapy. 2000; 20:429-35.
31. Malone DC, Carter BL, Billups SJ et al. An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans: the IMPROVE study. Pharmacotherapy. 2000; 20:1149-58.
32. Carmichael JM, Stander M. Antibiotic prophylaxis for dental procedures. US Pharm. 2000; 25(2):54-60.
33. Ellis SL, Carter BL, Malone DC et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Pharmacotherapy. 2000; 20:1508-16.
34. Malone DC, Carter BL, Billups SJ et al. Can clinical pharmacists affect SF-36 scores in veterans at high risk for medication-related problems? Med Care. 2001; 39:113-22.
35. Carter BL, Malone DC, Billups SJ et al. Interpreting the findings of the IMPROVE study. Am J Health-Syst Pharm. 2001; 58:1330-7.